PANACEA BIOTEC
|
The Current P/E Ratio of PANACEA BIOTEC is -327.47.
| Share Price | ₹406.0 | Jan 09,2026 |
| Market Cap | ₹2,488.8 Cr | |
| Earnings-TTM | ₹-7.6 Cr | TTM-Consolidated Results |
| Price/Earnings | -327.47x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PANACEA BIOTEC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,488.8 Cr] as on Jan 09,2026
(/) Earnings [ ₹-7.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -327.47x ]
Thus, for PANACEA BIOTEC , the investors are currently willing to pay -327.47 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PANACEA BIOTEC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PANACEA BIOTEC over the last five years.
Historical PE (Price/Earnings) ratio chart of PANACEA BIOTEC
PE Ratio Performance Analysis for PANACEA BIOTEC
- PANACEA BIOTEC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.17x.
- PANACEA BIOTEC 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PANACEA BIOTEC 's p/e ratio peaked in Mar2022 at 0.84x.
- PANACEA BIOTEC 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does PANACEA BIOTEC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| PANACEA BIOTEC | -7.60 | -327.47 | 2,488.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 39.46 | 415,073.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 70.69 | 175,657.0 |
| CIPLA LTD | 5,453.86 | 21.72 | 118,431.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 62.67 | 134,121.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.64 | 100,944.0 |
| MANKIND PHARMA LTD | 1,767.06 | 51.39 | 90,806.8 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.11 | 90,052.9 |
| LUPIN LTD | 4,347.53 | 22.92 | 99,648.4 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.19 | 69,609.1 |
| ABBOTT INDIA LTD | 1,508.95 | 39.49 | 59,589.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PANACEA BIOTEC 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -327.47x |
| Max industry PE | 70.69x |
| Median industry PE | 22.92x |
| Average industry PE | 3.35x |
You may also like the below Video Courses